The global brain imaging devices market size is estimated to reach USD 9.03 billion by 2030, registering to grow at a CAGR of 8.2% from 2025 to 2030 according to a new report by Grand View Research, Inc. Key drivers propelling market growth include technological advancements, increasing R&D activities, and the growing prevalence of brain or neurological disorders. For instance, the International Agency for Research on Cancer reported approximately 321,731 cases of brain and central nervous system cancer worldwide in 2022. This type of cancer was noted to rank 19th among all other types of cancer.
Technological advancements are expected to be one of the primary factors contributing to market growth. These advancements encompass a spectrum of innovations, including enhanced imaging resolution, improved data processing capabilities, and the development of novel imaging modalities. Such progress not only enhances the accuracy and efficiency of brain imaging but also expands its applications across various fields such as neuroscience, neurology, psychiatry, and neurosurgery. For instance, in February 2024, Philips partnered with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions, to introduce Smart Quant Neuro 3D, marking a notable advancement in providing objective decision support for the diagnosis and assessment of therapy effectiveness in brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. The Smart Quant Neuro 3D technology provides automated measurements of various brain tissues, aids in decision-making for brain diseases, monitors disease progression, and assesses therapy results.
Additionally, the rising prevalence of neurological disorders and an aging population contribute to the increasing demand for advanced brain imaging technologies. With continuous research and development efforts driving innovation and the expansion of the market. Furthermore, various initiatives undertaken by market players are further expected to contribute to market growth. For instance, in November 2022, Neurosteer secured FDA approval for its single-channel electroencephalogram (EEG) brain monitoring platform. The company innovatively improved the conventional EEG system by incorporating an adhesive-backed electrode strip, seamlessly linking to a compact sensor, thus offering a more simplified and user-friendly solution.
Request a free sample copy or view report summary: Brain Imaging Devices Market Report
The devices segment dominated the market with the largest revenue share of 81.5% in 2024.
The brain tumor segment held the largest revenue share in 2024, attributed to the increasing prevalence of the condition.
The fixed segment dominated the brain imaging devices industry with the largest revenue share in 2024.
The hospital segment held the largest revenue share in 2024.
Grand View Research has segmented the global brain imaging devices market based on product, application, modality, end use, and region:
Brain Imaging Devices Product Outlook (Revenue, USD Million, 2018 - 2030)
Devices
EEG
MEG
MRI
CT
PET
Other Devices
Accessories
Electrodes
Sensors
Other Accessories
Brain Imaging Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Stroke
Brain Tumor
Traumatic Brain Injury (TBI)
Epilepsy
Sleep Apnea
Headache
Structural Anomalies
Other Applications
Brain Imaging Devices Modality Outlook (Revenue, USD Million, 2018 - 2030)
Fixed
Portable
Wearable
Brain Imaging Devices End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Diagnostic Imaging Centers
Ambulatory Surgery Centers
Other End Users
Brain Imaging Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Brain Imaging Devices Market
GE HealthCare
Koninklijke Philips N.V.
Siemens Healthineers AG
Medtronic
Compumedics Limited
MEGIN
CTF MEG NEURO INNOVATIONS, INC.
FieldLine Inc.
Cerca Magnetics Limited
Advanced Brain Monitoring, Inc.
Canon Medical Systems Corporation
Natus
Magstim EGI
Cadwell Industries Inc.
Nihon Kohden Corporation
NeuroLogica Corp.
"The quality of research they have done for us has been excellent..."